145 related articles for article (PubMed ID: 31632154)
1. Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection.
Tripathi S; Nikhare A; Sharma G; Shea T; Albrecht H
Drug Healthc Patient Saf; 2019; 11():87-94. PubMed ID: 31632154
[TBL] [Abstract][Full Text] [Related]
2. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections.
Albrecht HH; Dicpinigaitis PV; Guenin EP
Multidiscip Respir Med; 2017; 12():31. PubMed ID: 29238574
[TBL] [Abstract][Full Text] [Related]
3. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections.
Hoffer-Schaefer A; Rozycki HJ; Yopp MA; Rubin BK
Respir Care; 2014 May; 59(5):631-6. PubMed ID: 24003241
[TBL] [Abstract][Full Text] [Related]
4. Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief in Support of a Wait-and-See Approach for the Treatment of Acute Upper Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Study.
Septimus EJ; Albrecht HH; Solomon G; Shea T; Guenin EP
Curr Ther Res Clin Exp; 2017; 84():54-61. PubMed ID: 28761581
[TBL] [Abstract][Full Text] [Related]
5. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.
Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK
Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Studies in Healthy Subjects for the Development of an Extended-Release Tablet Formulation of Guaifenesin: A 505(b)(2) New Drug Application Approval.
Vilson L; Owen JS
Clin Pharmacol Drug Dev; 2013 Jan; 2(1):25-32. PubMed ID: 27121557
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms.
Albrecht H; Vernon M; Solomon G
Respir Res; 2012 Dec; 13(1):118. PubMed ID: 23270519
[TBL] [Abstract][Full Text] [Related]
8. Improved lung function and quality of life following guaifenesin treatment in a patient with chronic obstructive pulmonary disease (COPD): A case report.
Storms WW; Miller JE
Respir Med Case Rep; 2018; 24():84-85. PubMed ID: 29977767
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis].
Zaitsev AA; Leshchenko IV; Esaulova NA; Viktorova IA
Ter Arkh; 2023 Apr; 95(3):236-242. PubMed ID: 37167145
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections.
LaForce C; Gentile DA; Skoner DP
Postgrad Med; 2008 Jul; 120(2):53-9. PubMed ID: 18654069
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy.
Jeyakumar A; Brickman TM; Haben M
Laryngoscope; 2006 Dec; 116(12):2108-12. PubMed ID: 17146380
[TBL] [Abstract][Full Text] [Related]
12. [A prospective multicenter randomized controlled clinical study on the efficacy and safety of Guaifenesin compound pseudoephedrine hydrochloride oral solution].
; Lu Q
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):204-7. PubMed ID: 20426957
[TBL] [Abstract][Full Text] [Related]
13. Effect of guaifenesin on cough reflex sensitivity.
Dicpinigaitis PV; Gayle YE
Chest; 2003 Dec; 124(6):2178-81. PubMed ID: 14665498
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tolerability of extended-release clarithromycin.
Guay DR; Gustavson LE; Devcich KJ; Zhang J; Cao G; Olson CA
Clin Ther; 2001 Apr; 23(4):566-77. PubMed ID: 11354390
[TBL] [Abstract][Full Text] [Related]
15. Guaifenesin in rhinitis.
Storms W; Farrar JR
Curr Allergy Asthma Rep; 2009 Mar; 9(2):101-6. PubMed ID: 19210898
[TBL] [Abstract][Full Text] [Related]
16. Daily use of guaifenesin (Mucinex) in a patient with chronic bronchitis and pathologic mucus hypersecretion: A case report.
Storms WW; Miller JE
Respir Med Case Rep; 2018; 23():156-157. PubMed ID: 29719806
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study.
Prabhu Shankar S; Chandrashekharan S; Bolmall CS; Baliga V
J Indian Med Assoc; 2010 May; 108(5):313-4, 316-8, 320. PubMed ID: 21121410
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial.
Smith JA; Kitt MM; Bell A; Noulin N; Tzontcheva A; Seng MM; Lu S
Pulm Ther; 2022 Sep; 8(3):297-310. PubMed ID: 35969360
[TBL] [Abstract][Full Text] [Related]
19. Over-the-counter medications for acute cough in children and adults in ambulatory settings.
Schroeder K; Fahey T
Cochrane Database Syst Rev; 2004 Oct; (4):CD001831. PubMed ID: 15495019
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
